Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Petrie

Showing results (461-470 of 557) with videos related to

Pageof 56
Sort By:
Circulation|November 19, 2019
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFFelipe A Martinez, Matteo Serenelli, Jose C Nicolau, et al.
Circulation. Heart Failure|December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection FractionPooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Circulation. Heart Failure|November 18, 2016
One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection FractionDavid M Kaye, Gerd Hasenfuß, Petr Neuzil, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
Circulation. Heart Failure|November 22, 2021
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF TrialJawad H Butt, Carly Adamson, Kieran F Docherty, et al.
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
Heart (British Cardiac Society)|January 13, 2021
Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trialAnnette Marie Maznyczka, Peter McCartney, Patrycja Duklas, et al.
The New England Journal of Medicine|July 6, 2017
Declining Risk of Sudden Death in Heart FailureLi Shen, Pardeep S Jhund, Mark C Petrie, et al.
European Journal of Heart Failure|September 12, 2025
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-OncologyKalliopi Keramida, Teresa Lopez-Fernandez, Markus S Anker, et al.
The New England Journal of Medicine|April 6, 2011
Coronary-artery bypass surgery in patients with left ventricular dysfunctionEric J Velazquez, Kerry L Lee, Marek A Deja, et al.
Pageof 56

Showing results (461-470 of 557) with videos related to

Sort By:
Pageof 56
Circulation|November 19, 2019
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFFelipe A Martinez, Matteo Serenelli, Jose C Nicolau, et al.
Circulation. Heart Failure|December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection FractionPooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Circulation. Heart Failure|November 18, 2016
One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection FractionDavid M Kaye, Gerd Hasenfuß, Petr Neuzil, et al.
European Journal of Heart Failure|October 25, 2024
Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trialPaul W Foley, Paul R Kalra, John G F Cleland, et al.
Circulation. Heart Failure|November 22, 2021
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF TrialJawad H Butt, Carly Adamson, Kieran F Docherty, et al.
American Journal of Nephrology|June 29, 2025
Effects of Ferric Derisomaltose in Heart Failure with Iron Deficiency according to Renal Function in the IRONMAN Randomised Controlled TrialFozia Z Ahmed, Paul R Kalra, John G F Cleland, et al.
Heart (British Cardiac Society)|January 13, 2021
Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trialAnnette Marie Maznyczka, Peter McCartney, Patrycja Duklas, et al.
The New England Journal of Medicine|July 6, 2017
Declining Risk of Sudden Death in Heart FailureLi Shen, Pardeep S Jhund, Mark C Petrie, et al.
European Journal of Heart Failure|September 12, 2025
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-OncologyKalliopi Keramida, Teresa Lopez-Fernandez, Markus S Anker, et al.
The New England Journal of Medicine|April 6, 2011
Coronary-artery bypass surgery in patients with left ventricular dysfunctionEric J Velazquez, Kerry L Lee, Marek A Deja, et al.
Pageof 56